February 27, 2017 |


IOWA CITY, IA, February 27, 2017– IDx, LLC, an Iowa City based company, has joined the IBM Watson Health medical imaging collaborative. The initiative is comprised of a select group of worldwide organizations in healthcare and technology. Together these organizations are finding ways to use cognitive imaging to identify and predict the risk in cases of cancer, diabetes, and diseases of the eye, brain and heart and related conditions.

As part of the collaborative, IDx will be leveraging IBM’s cognitive computing system, Watson. Watson is a cloud-based system that analyzes high volumes of data, understands complex questions in everyday language, and proposes evidence-based answers. Watson continuously learns, gaining knowledge over time, from previous interactions. Data comes from structured and unstructured sources, such as medical imaging data, electronic health records, radiology and pathology reports, lab results, doctors’ progress notes, medical journals, clinical care guidelines and published outcomes studies.

“IDx is tremendously pleased that IBM recognizes the value that IDx will contribute to the Watson Health Imaging Collaborative, especially given the caliber of the other 23 current members.” said Dr. Michael Abramoff, President and Founder at IDx, LLC, and The Robert C. Watzke Professor of Ophthalmology and Visual Sciences at the Roy C. and Lucille A. Carver College of Medicine.  “Over the past decades, productivity in healthcare has not kept pace with other sectors. Patients and providers worldwide are paying the price. Our mission at IDx has always been to transform the quality, accessibility, and affordability of global healthcare through the automation of medical screening and diagnosis.”

IDx Chairman and CEO, Gary Seamans added “We are profoundly excited to be working with IBM at this critical juncture in medical history. Partnering with IBM will help us bring the greatest benefit to patients and providers.”

This collaboration compliments IDx’s mission as they have been working to transform quality, accessibility, and affordability in healthcare through the introduction of automated, image-based screening tools. The company’s founders, including world leading retina experts from the University of Iowa, have selected the eye as its key starting point for disease detection.

“We have known for some time that IDx was on the brink of transformational diagnostic technology. We are so thrilled that their hard work has been recognized by this IBM collaborative.” Mark Nolte, President of the Iowa City Area Development Group said in a statement.

# # #

If you would like more information about this topic, please contact Iowa City Area Development Group for IDx, LLC at 319-354-3939 or email at